International journal of chronic obstructive pulmonary disease · 2026
The Development and Initial Psychometric Testing of a Patient-Reported Outcome Measure to Assess COPD-Related Emotional Distress.
СтатьяВалидационное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Schmid-Mohler Gabriela, Hübsch Christine, Mueller Marianne, Imhof Rafael, Jordan Katja-Daniela, Clarenbach Christian, Monsch Gian-Marco, Yorke Janelle
Аннотация
PURPOSE: Emotional distress is prevalent in patients with COPD and highly relevant to patients. Research in chronic disease indicates that illness-related emotional distress might be specific and sensitive enough to explain self-management behaviour. However, as no currently available instrument assesses COPD-related emotional distress (CRED), it has only been assessed regarding overall distress, using mainly anxiety and depression as outcomes. Therefore, this study aimed to develop and test a preliminary item list to measure CRED.
PATIENTS AND METHODS: Following Food and Drug Administration (FDA) guidelines, a multistep mixed-method study was conducted. Based on an earlier qualitative study and literature review, a conceptual framework and item list were developed. The item list's content validity was assessed via patient interviews using cognitive debriefing techniques and a survey involving a panel of clinicians. Finally, its psychometric properties were tested in a cross-sectional study. Construct validity was established by comparing the CRED-V1 with established questionnaires like the COPD Assessment Test (CAT), the Hospital Anxiety and Depression Scale (HADS), and the modified Medical Research Counsel (mMRC) dyspnoea scale.
RESULTS: The first German COPD-Related Emotional Distress questionnaire-version 1 (CRED-V1) contained 36 items. Its content validity was confirmed by nine patients and ten clinicians. Psychometric testing in 264 patients with COPD revealed two formative (symptom- and treatment-related) and four reflective (restricted mobility-, restricted relationship-, disease unpredictability- and stigma-related) subcategories. For all reflective subscales, Cronbach's alpha values were >0.8. Structural equation modelling was possible for 32 items: An R2 value of 0.656 allowed the calculation of a CRED total score (CRED-TS). A regression model using the CRED-TS as the outcome variable showed that the most important explanatory variables were the CAT and HADS depression scores.
CONCLUSION: This work reports the initial development of a new innovative tool for the assessment of CRED in patients with COPD.
PATIENTS AND METHODS: Following Food and Drug Administration (FDA) guidelines, a multistep mixed-method study was conducted. Based on an earlier qualitative study and literature review, a conceptual framework and item list were developed. The item list's content validity was assessed via patient interviews using cognitive debriefing techniques and a survey involving a panel of clinicians. Finally, its psychometric properties were tested in a cross-sectional study. Construct validity was established by comparing the CRED-V1 with established questionnaires like the COPD Assessment Test (CAT), the Hospital Anxiety and Depression Scale (HADS), and the modified Medical Research Counsel (mMRC) dyspnoea scale.
RESULTS: The first German COPD-Related Emotional Distress questionnaire-version 1 (CRED-V1) contained 36 items. Its content validity was confirmed by nine patients and ten clinicians. Psychometric testing in 264 patients with COPD revealed two formative (symptom- and treatment-related) and four reflective (restricted mobility-, restricted relationship-, disease unpredictability- and stigma-related) subcategories. For all reflective subscales, Cronbach's alpha values were >0.8. Structural equation modelling was possible for 32 items: An R2 value of 0.656 allowed the calculation of a CRED total score (CRED-TS). A regression model using the CRED-TS as the outcome variable showed that the most important explanatory variables were the CAT and HADS depression scores.
CONCLUSION: This work reports the initial development of a new innovative tool for the assessment of CRED in patients with COPD.